Inflammatory diseases of the ED should be treated topical nonsteroidal antiinflammatory drugs

Inflammatory joint disease should be treated with topical nonsteroidal anti-inflammatory drugs
Inflammatory joint disease should be treated with topical nonsteroidal anti-inflammatory drugs (NSAIDs), said the Food and Drug Administration United States and the National Institute of Clinical Excellence (NICE) UK. Now they belong to the first-line therapy of all kinds of arthritis, called the post-arthrosis.

Despite the fact that NSAIDs are used for this purpose for a long time, they are licensed in the United States only in 2007 and in the UK - in 2008.

Topical NSAIDs real alternative to oral administration because of a much smaller cheep side effects.

Note that they are especially effective in combination with irritant gels and ointments that through the improvement of local blood circulation increase their rate of absorption and thus potentiate the anti-anginal and his ilk action.

Take it as interesting, especially if the seasonal atriticheskoy atropaticheskoy, who gives a definition more like it, come.

Diseases

Описание:

Get book «Ankylosing spondylitis. What is ankylosing spondylitis?» - http://e08cc5kl3m84f9svycfb1z1y8r.hop...
What is ankylosing spondylitis? Ankylosing spondylitis - a chronic systemic disease of the joints.
Read the article "Ankylosing spondylitis. What is ankylosing spondylitis?" on the page - http://treatment-wiki.com/ankylosing-...
Follow us on:
Facebook https://www.facebook.com/pages/Treatm...
Google+ https://plus.google.com/u/0/b/1109387...
Twitter https://twitter.com/harry_bear
Watch Playlist - https://www.youtube.com/playlist?feat...
Watch Video Ankylosing spondylitis. What is ankylosing spondylitis? - http://www.youtube.com/watch?v=afK1ew...
You did not forget to Subscribe and Like?
Summary "Ankylosing spondylitis. What is ankylosing spondylitis?"
Ankylosing spondylitis prevalence varies widely and depends primarily on the frequency of occurrence ar HLA-B27: from 0.15% in France to 1.4% in Norway (adult). Prevalence of ankylosing spondylitis in Russia, according to epidemiological research, 1988, ranging from 0.01% to 0.09%. The disease develops mostly in the age of 20-30 years in males approximately 5 times more.
The etiology and pathogenesis of ankylosing spondylitis
There is information about the role of certain strains of Klebsiella and other enters bacteria in the development of peripheral arthritis in patients with BB. The most important factor in the pathogenesis of a family history, which is considered a marker of histocompatibility antigen HLA - B27.
The defeat of the axial skeleton in ankylosing spondylitis prevails over the involvement of the peripheral joints, and the joints are mainly affected "cartilage" type. the sacroiliac joint, the small vertebral joints, sternal clavicular and sternal edge. joint. Inflammation of the joints caused by immunological mechanisms. This is evidenced by infiltration of lymphocytes and macrophages, the rapid development of fibrous scar tissue. Of gross destructive changes in the joints is observed.
Clinic ankylosing spondylitis...